A comparison of five epidemiological models for transmission of SARS-CoV-2 in India

被引:25
|
作者
Purkayastha, Soumik [1 ]
Bhattacharyya, Rupam [1 ]
Bhaduri, Ritwik [2 ]
Kundu, Ritoban [2 ]
Gu, Xuelin [1 ,3 ]
Salvatore, Maxwell [1 ,3 ,4 ]
Ray, Debashree [5 ,6 ]
Mishra, Swapnil [7 ]
Mukherjee, Bhramar [1 ,3 ,4 ]
机构
[1] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[2] Indian Stat Inst, Kolkata 700108, W Bengal, India
[3] Univ Michigan, Ctr Precis Hlth Data Sci, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA
[7] Imperial Coll London, Sch Publ Hlth, London W2 1PG, England
关键词
Compartmental models; Low and middle income countries; Prediction uncertainty; Statistical models; COVID-19;
D O I
10.1186/s12879-021-06077-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Many popular disease transmission models have helped nations respond to the COVID-19 pandemic by informing decisions about pandemic planning, resource allocation, implementation of social distancing measures, lockdowns, and other non-pharmaceutical interventions. We study how five epidemiological models forecast and assess the course of the pandemic in India: a baseline curve-fitting model, an extended SIR (eSIR) model, two extended SEIR (SAPHIRE and SEIR-fansy) models, and a semi-mechanistic Bayesian hierarchical model (ICM). Methods Using COVID-19 case-recovery-death count data reported in India from March 15 to October 15 to train the models, we generate predictions from each of the five models from October 16 to December 31. To compare prediction accuracy with respect to reported cumulative and active case counts and reported cumulative death counts, we compute the symmetric mean absolute prediction error (SMAPE) for each of the five models. For reported cumulative cases and deaths, we compute Pearson's and Lin's correlation coefficients to investigate how well the projected and observed reported counts agree. We also present underreporting factors when available, and comment on uncertainty of projections from each model. Results For active case counts, SMAPE values are 35.14% (SEIR-fansy) and 37.96% (eSIR). For cumulative case counts, SMAPE values are 6.89% (baseline), 6.59% (eSIR), 2.25% (SAPHIRE) and 2.29% (SEIR-fansy). For cumulative death counts, the SMAPE values are 4.74% (SEIR-fansy), 8.94% (eSIR) and 0.77% (ICM). Three models (SAPHIRE, SEIR-fansy and ICM) return total (sum of reported and unreported) cumulative case counts as well. We compute underreporting factors as of October 31 and note that for cumulative cases, the SEIR-fansy model yields an underreporting factor of 7.25 and ICM model yields 4.54 for the same quantity. For total (sum of reported and unreported) cumulative deaths the SEIR-fansy model reports an underreporting factor of 2.97. On October 31, we observe 8.18 million cumulative reported cases, while the projections (in millions) from the baseline model are 8.71 (95% credible interval: 8.63-8.80), while eSIR yields 8.35 (7.19-9.60), SAPHIRE returns 8.17 (7.90-8.52) and SEIR-fansy projects 8.51 (8.18-8.85) million cases. Cumulative case projections from the eSIR model have the highest uncertainty in terms of width of 95% credible intervals, followed by those from SAPHIRE, the baseline model and finally SEIR-fansy. Conclusions In this comparative paper, we describe five different models used to study the transmission dynamics of the SARS-Cov-2 virus in India. While simulation studies are the only gold standard way to compare the accuracy of the models, here we were uniquely poised to compare the projected case-counts against observed data on a test period. The largest variability across models is observed in predicting the "total" number of infections including reported and unreported cases (on which we have no validation data). The degree of under-reporting has been a major concern in India and is characterized in this report. Overall, the SEIR-fansy model appeared to be a good choice with publicly available R-package and desired flexibility plus accuracy.
引用
收藏
页数:23
相关论文
共 50 条
  • [11] Natural Transmission and Experimental Models of SARS-CoV-2 Infection in Animals
    Noll, Jessica C. Gomes
    do Nascimento, Gabriela M.
    Diel, Diego G.
    COMPARATIVE MEDICINE, 2021, 71 (05) : 369 - 382
  • [12] SARS-CoV-2 re-infection: development of an epidemiological definition from India
    Mukherjee, Aparna
    Anand, Tanu
    Agarwal, Anup
    Singh, Harpreet
    Chatterjee, Pranab
    Narayan, Jitendra
    Rana, Salaj
    Gupta, Nivedita
    Bhargava, Balram
    Panda, Samiran
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [13] Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland
    McDonald, Lindsay
    Wise, Helen
    Muecksch, Frauke
    Poston, Daniel
    Mavin, Sally
    Templeton, Kate
    Furrie, Elizabeth
    Richardson, Claire
    McGuire, Jaqueline
    Jarvis, Lisa
    Malloy, Kristen
    McAuley, Andrew
    Palmateer, Norah
    Dickson, Elizabeth
    Hatziioannou, Theodora
    Bieniasz, Paul
    Jenks, Sara
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [14] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
    Lee, Byung Uk
    AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
  • [15] Animal models for SARS-CoV-2
    Lee, Chung-Young
    Lowen, Anice C.
    CURRENT OPINION IN VIROLOGY, 2021, 48 : 73 - 81
  • [16] Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies
    Park, Younhee
    Hong, Ki Ho
    Lee, Su-Kyung
    Hyun, Jungwon
    Oh, Eun-Jee
    Lee, Jaehyeon
    Lee, Hyukmin
    Song, Sang Hoon
    Kee, Seung-Jung
    Kwon, Gye Cheol
    Kim, Su Hwan
    Do, Hyeon-Nam
    Kim, Ah-Ra
    Lee, June-Woo
    Kim, Sung Soon
    Kim, Hyun Soo
    ANNALS OF LABORATORY MEDICINE, 2022, 42 (01) : 71 - +
  • [17] SARS-CoV-2 Neutralizing Antibodies in Mexican Population: A Five Vaccine Comparison
    Alcorta-Nunez, Fernando
    Perez-Ibave, Diana Cristina
    Burciaga-Flores, Carlos Horacio
    Garza, Miguel Angel
    Gonzalez-Escamilla, Moises
    Rodriguez-Nino, Patricia
    Gonzalez-Guerrero, Juan Francisco
    Alcorta-Garza, Adelina
    Vidal-Gutierrez, Oscar
    Ramirez-Correa, Genaro A.
    Garza-Rodriguez, Maria Lourdes
    DIAGNOSTICS, 2023, 13 (06)
  • [18] Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2
    Kanwar, Neena
    Banerjee, Dithi
    Sasidharan, Anjana
    Abdulhamid, Ayah
    Larson, Marissa
    Lee, Brian
    Selvarangan, Rangaraj
    Liesman, Rachael M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 101 (04)
  • [19] The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
    Rebecca S. Y. Wong
    SN Comprehensive Clinical Medicine, 2020, 2 (11) : 1983 - 1991
  • [20] Epidemiological and Immunological Features of Obesity and SARS-CoV-2
    Nilles, Eric J.
    Siddiqui, Sameed M.
    Fischinger, Stephanie
    Bartsch, Yannic C.
    de St Aubin, Michael
    Zhou, Guohai
    Gluck, Matthew J.
    Berger, Samuel
    Rhee, Justin
    Petersen, Eric
    Mormann, Benjamin
    Loesche, Michael
    Hu, Yiyuan
    Chen, Zhilin
    Yu, Jingyou
    Gebre, Makda
    Atyeo, Caroline
    Gorman, Matthew J.
    Zhu, Alex Lee
    Burke, John
    Slein, Matthew
    Hasdianda, Mohammad A.
    Jambaulikar, Guruprasad
    Boyer, Edward W.
    Sabeti, Pardis C.
    Barouch, Dan H.
    Julg, Boris
    Kucharski, Adam J.
    Musk, Elon R.
    Lauffenburger, Douglas A.
    Alter, Galit
    Menon, Anil S.
    VIRUSES-BASEL, 2021, 13 (11):